Stockscreener 앱 받기
1.06
0.93%
-0.01
시간 외 거래:
1.06
전일 마감가:
$1.07
열려 있는:
$1.06
하루 거래량:
185.64K
Relative Volume:
0.37
시가총액:
$25.07M
수익:
-
순이익/손실:
$-14.33M
주가수익비율:
-1.6061
EPS:
-0.66
순현금흐름:
$-13.21M
1주 성능:
+0.95%
1개월 성능:
-23.74%
6개월 성능:
-6.19%
1년 성능:
-13.82%
1일 변동 폭
$1.05
$1.08
1주일 범위
$1.01
$1.08
52주 변동 폭
$0.8101
$2.10
엔라이벡스 Stock (ENLV) Company Profile
ENLV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
1.06 | 25.52M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
엔라이벡스 Stock (ENLV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-02 | 재확인 | H.C. Wainwright | Buy |
엔라이벡스 주식(ENLV)의 최신 뉴스
Will Enlivex Therapeutics Ltd. outperform the marketPortfolio Update Report & Verified Momentum Watchlists - Newser
Will Enlivex Therapeutics Ltd. benefit from geopolitical trends2025 Volume Leaders & Reliable Volume Spike Trade Alerts - خودرو بانک
What dividend growth rate does Enlivex Therapeutics Ltd. offerJuly 2025 Spike Watch & High Accuracy Swing Entry Alerts - خودرو بانک
Applying Wyckoff theory to Enlivex Therapeutics Ltd. stock2025 Growth vs Value & Smart Allocation Stock Reports - Newser
Is Enlivex Therapeutics Ltd. a momentum stockWatch List & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Published on: 2025-09-05 16:48:27 - خودرو بانک
Can technical indicators confirm Enlivex Therapeutics Ltd.’s reversalBear Alert & AI Enhanced Trade Execution Alerts - Newser
Understanding Enlivex Therapeutics Ltd.’s price movement2025 Top Gainers & Fast Moving Stock Trade Plans - Newser
Will Enlivex Therapeutics Ltd. rebound enough to break evenJuly 2025 Rallies & Stepwise Trade Signal Implementation - Newser
When is the best time to exit Enlivex Therapeutics Ltd.Market Growth Review & AI Driven Price Forecasts - Newser
How moving averages guide Enlivex Therapeutics Ltd. tradingQuarterly Market Summary & Weekly Chart Analysis and Guides - Newser
HC Wainwright Has Bullish Estimate for ENLV Q3 Earnings - Defense World
Is Enlivex Therapeutics Ltd. a stock for growth or value investorsJuly 2025 Gainers & Long Hold Capital Preservation Plans - خودرو بانک
Is Enlivex Therapeutics Ltd. building a consolidation baseWeekly Investment Report & Weekly Stock Performance Updates - Newser
Is Enlivex Therapeutics Ltd. a candidate for recovery playTrade Volume Summary & Fast Entry High Yield Tips - Newser
Will Enlivex Therapeutics Ltd. stock go up soonIPO Watch & Free Weekly Chart Analysis and Trade Guides - Newser
Will breakout in Enlivex Therapeutics Ltd. lead to full recoveryEarnings Recap Summary & Safe Investment Capital Preservation Plans - Newser
How to manage a losing position in Enlivex Therapeutics Ltd.Quarterly Performance Summary & Daily Market Momentum Tracking - Newser
Is it time to cut losses on Enlivex Therapeutics Ltd.July 2025 Reactions & Consistent Return Strategy Ideas - Newser
Quantitative breakdown of Enlivex Therapeutics Ltd. recent moveWeekly Trade Report & Low Risk High Reward Trade Ideas - Newser
Measuring Enlivex Therapeutics Ltd.’s beta against major indicesQuarterly Profit Report & Real-Time Volume Analysis Alerts - Newser
Q1 Earnings Estimate for ENLV Issued By HC Wainwright - Defense World
Using data filters to optimize entry into Enlivex Therapeutics Ltd.2025 Year in Review & Free Expert Verified Stock Movement Alerts - Newser
Multi asset correlation models including Enlivex Therapeutics Ltd.Weekly Market Summary & Expert Approved Momentum Ideas - Newser
Relative strength of Enlivex Therapeutics Ltd. in sector analysisQuarterly Market Summary & Daily Price Action Insights - Newser
Applying big data sentiment scoring on Enlivex Therapeutics Ltd.July 2025 Gainers & Pattern Based Trade Signal System - Newser
Will Enlivex Therapeutics Ltd. stock hit new highs in YEARLong Setup & Weekly Breakout Watchlists - خودرو بانک
Volatility clustering patterns for Enlivex Therapeutics Ltd.2025 Institutional Moves & Accurate Entry/Exit Alerts - Newser
Is Enlivex Therapeutics Ltd. on track to beat earnings2025 Earnings Impact & Low Drawdown Investment Ideas - خودرو بانک
Real time pattern detection on Enlivex Therapeutics Ltd. stockEarnings Miss & Smart Money Movement Tracker - Newser
Is Enlivex Therapeutics Ltd. trending in predictive chart models2025 AllTime Highs & Technical Analysis for Trade Confirmation - Newser
How sensitive is Enlivex Therapeutics Ltd. to inflationIndex Update & AI Based Buy/Sell Signal Reports - خودرو بانک
Identifying reversal signals in Enlivex Therapeutics Ltd.2025 Market Trends & Daily Growth Stock Investment Tips - Newser
What earnings revisions data tells us about Enlivex Therapeutics Ltd.July 2025 Market Mood & High Accuracy Trade Signal Alerts - Newser
Aug Action: What is the next catalyst for Enlivex Therapeutics Ltd.Weekly Profit Recap & Capital Efficient Trading Techniques - خودرو بانک
Published on: 2025-09-02 02:11:50 - Newser
Why Enlivex Therapeutics Ltd. is moving todayPortfolio Gains Summary & Expert Approved Momentum Ideas - Newser
Will a bounce in Enlivex Therapeutics Ltd. offer an exitTrade Analysis Summary & Real-Time Buy Signal Notifications - Newser
What is the next catalyst for Enlivex Therapeutics Ltd.2025 Volatility Report & Accurate Entry and Exit Point Alerts - خودرو بانک
Aug Macro: Is Enlivex Therapeutics Ltd.’s ROE strong enoughPortfolio Performance Summary & Free Safe Entry Trade Signal Reports - خودرو بانک
How to build a dashboard for Enlivex Therapeutics Ltd. stockJuly 2025 Snapshot & Entry and Exit Point Strategies - Newser
Can Enlivex Therapeutics Ltd. Regain Lost Ground This Quarter2025 Technical Overview & Stock Portfolio Risk Control - beatles.ru
엔라이벡스 (ENLV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):